RIG
IONS icon

Roosevelt Investment Group’s Ionis Pharmaceuticals IONS Stock Holding History

Roosevelt Investment Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-374,168
Closed -$16.2M – 232
2014
Q1 		$16.2M Buy
+374,168
New +$18.1M 0.75% 38

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Roosevelt Investment Group's IONS Position: Q2 2014 in Review

Roosevelt Investment Group sold out of Ionis Pharmaceuticals (IONS) in Q2 2014, closing a stake of 374,168 shares — an estimated $16.2M sold.

Roosevelt Investment Group first reported a position in IONS in Q1 2014 and held it in 1 quarter. The position peaked at $16.2M in Q1 2014. 238 funds tracked by Wall St. Rank hold IONS as of Q2 2014.

  • Roosevelt Investment Group reported no remaining Ionis Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Roosevelt Investment Group sold 374,168 Ionis Pharmaceuticals shares in Q2 2014, an estimated $16.2M.
  • Roosevelt Investment Group first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • Roosevelt Investment Group's Ionis Pharmaceuticals position peaked at $16.2M in Q1 2014.
  • 238 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2014.

Based on Roosevelt Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.